AMN Healthcare prices $400 million 6.500% senior notes due 2031
AMN Healthcare completed a $400.0 million offering of 6.500% senior notes due 2031 and amended its credit agreement on October 6, 2025. The company expects to use the notes proceeds, approximately $100.0 million of revolver borrowings and cash on hand to redeem its $500.0 million of 2027 notes on October 22, 2025. The amendment cuts the secured revolving facility to $450.0 million from $750.0 million and extends its maturity to October 6, 2030, which reshapes the company's debt maturities and borrowing capacity for shareholders.
Key points
- $400.0 million of 6.500% senior notes due January 15, 2031 issued by AMN Healthcare, Inc., with interest payable semi-annually starting July 15, 2026
- Expected redemption of all $500.0 million of 2027 notes on October 22, 2025, funded by the new notes, about $100.0 million of revolver borrowings and cash on hand
- Secured revolving credit facility reduced to $450.0 million from $750.0 million and extended to October 6, 2030 from February 2028
- Net leverage ratio covenant set at no greater than 5.25 to 1.00 through March 31, 2027, stepping down to 5.00 to 1.00 and then 4.75 to 1.00 after June 30, 2028
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.